Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

669 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bromocriptine: a novel approach to the treatment of type 2 diabetes.
Pijl H, Ohashi S, Matsuda M, Miyazaki Y, Mahankali A, Kumar V, Pipek R, Iozzo P, Lancaster JL, Cincotta AH, DeFronzo RA. Pijl H, et al. Among authors: defronzo ra. Diabetes Care. 2000 Aug;23(8):1154-61. doi: 10.2337/diacare.23.8.1154. Diabetes Care. 2000. PMID: 10937514 Clinical Trial.
Rosiglitazone decreases albuminuria in type 2 diabetic patients.
Miyazaki Y, Cersosimo E, Triplitt C, DeFronzo RA. Miyazaki Y, et al. Among authors: defronzo ra. Kidney Int. 2007 Dec;72(11):1367-73. doi: 10.1038/sj.ki.5002516. Epub 2007 Sep 5. Kidney Int. 2007. PMID: 17805239 Free article. Clinical Trial.
Metabolic effects of muraglitazar in type 2 diabetic subjects.
Fernandez M, Gastaldelli A, Triplitt C, Hardies J, Casolaro A, Petz R, Tantiwong P, Musi N, Cersosimo E, Ferrannini E, DeFronzo RA. Fernandez M, et al. Among authors: defronzo ra. Diabetes Obes Metab. 2011 Oct;13(10):893-902. doi: 10.1111/j.1463-1326.2011.01429.x. Diabetes Obes Metab. 2011. PMID: 21615671 Clinical Trial.
Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): a randomized trial.
Abdul-Ghani MA, Puckett C, Triplitt C, Maggs D, Adams J, Cersosimo E, DeFronzo RA. Abdul-Ghani MA, et al. Among authors: defronzo ra. Diabetes Obes Metab. 2015 Mar;17(3):268-75. doi: 10.1111/dom.12417. Epub 2015 Jan 7. Diabetes Obes Metab. 2015. PMID: 25425451 Free PMC article. Clinical Trial.
669 results